 |
|
Z-360
A selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells.
Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Previous: | yttrium Y 90 monoclonal antibody Hu3S193, yttrium Y 90 monoclonal antibody MN-14, yttrium Y 90 resin microspheres, yttrium Y 90-DOTA-chimeric monoclonal antibody cG250, yttrium Y 90-edotreotide | | Next: | Zactima, zalcitabine, Zanosar, Zarnestra, ZD6126 |
|
|
